Search research articles
Contact Us
Filters
Showing results (351-360 of 524) with videos related to
Page
of 53
Sort By:
American Journal of Hematology
|
October 4, 2016
CD38, BCL-2, PD-1, and PD-1L expression in nodal peripheral T-cell lymphoma: Possible biomarkers for novel targeted therapies?
Francesco Zaja, Valentina Tabanelli, Claudio Agostinelli, et al.
Leukemia & Lymphoma
|
May 7, 1998
Immunohistochemistry of bone-marrow biopsy
S A Pileri, G Roncador, C Ceccarelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 5, 2002
Diffuse large B-cell lymphoma with primary retroperitoneal presentation: clinico-pathologic study of nine cases
S A Pileri, P L Zinzani, S Ascani, et al.
Advances in Hematology
|
February 19, 2011
Pathobiology of anaplastic large cell lymphoma
Pier Paolo Piccaluga, Anna Gazzola, Claudia Mannu, et al.
British Journal of Haematology
|
March 12, 2015
BRAF(V600E) mutations are found in Richter syndrome and may allow targeted therapy in a subset of patients
Rob S Sellar, Falko Fend, Ayse U Akarca, et al.
Leukemia Research
|
October 1, 1996
Combined differentiating therapy for myelodysplastic syndromes: a phase II study
D Ferrero, B Bruno, P Pregno, et al.
Bone Marrow Transplantation
|
September 11, 1998
Allogeneic transplantation of unmanipulated peripheral blood stem cells in patients with multiple myeloma
I Majolino, P Corradini, R Scimè, et al.
International Journal of Cancer
|
January 6, 2006
Cancer-associated carbohydrate identification in Hodgkin's lymphoma by carbohydrate array profiling
Charles H Lawrie, Teresa Marafioti, Christian S R Hatton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 13, 2000
Gemcitabine treatment in pretreated cutaneous T-cell lymphoma: experience in 44 patients
P L Zinzani, G Baliva, M Magagnoli, et al.
Leukemia
|
March 10, 2001
High-dose mitoxantrone + melphalan (MITO/L-PAM) as conditioning regimen supported by peripheral blood progenitor cell (PBPC) autograft in 113 lymphoma patients: high tolerability with reversible cardiotoxicity
C Tarella, F Zallio, D Caracciolo, et al.
Page
of 53
Search research articles
Search
Showing results (351-360 of 524) with videos related to
Sort By:
Page
of 53
American Journal of Hematology
|
October 4, 2016
CD38, BCL-2, PD-1, and PD-1L expression in nodal peripheral T-cell lymphoma: Possible biomarkers for novel targeted therapies?
Francesco Zaja, Valentina Tabanelli, Claudio Agostinelli, et al.
Leukemia & Lymphoma
|
May 7, 1998
Immunohistochemistry of bone-marrow biopsy
S A Pileri, G Roncador, C Ceccarelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 5, 2002
Diffuse large B-cell lymphoma with primary retroperitoneal presentation: clinico-pathologic study of nine cases
S A Pileri, P L Zinzani, S Ascani, et al.
Advances in Hematology
|
February 19, 2011
Pathobiology of anaplastic large cell lymphoma
Pier Paolo Piccaluga, Anna Gazzola, Claudia Mannu, et al.
British Journal of Haematology
|
March 12, 2015
BRAF(V600E) mutations are found in Richter syndrome and may allow targeted therapy in a subset of patients
Rob S Sellar, Falko Fend, Ayse U Akarca, et al.
Leukemia Research
|
October 1, 1996
Combined differentiating therapy for myelodysplastic syndromes: a phase II study
D Ferrero, B Bruno, P Pregno, et al.
Bone Marrow Transplantation
|
September 11, 1998
Allogeneic transplantation of unmanipulated peripheral blood stem cells in patients with multiple myeloma
I Majolino, P Corradini, R Scimè, et al.
International Journal of Cancer
|
January 6, 2006
Cancer-associated carbohydrate identification in Hodgkin's lymphoma by carbohydrate array profiling
Charles H Lawrie, Teresa Marafioti, Christian S R Hatton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 13, 2000
Gemcitabine treatment in pretreated cutaneous T-cell lymphoma: experience in 44 patients
P L Zinzani, G Baliva, M Magagnoli, et al.
Leukemia
|
March 10, 2001
High-dose mitoxantrone + melphalan (MITO/L-PAM) as conditioning regimen supported by peripheral blood progenitor cell (PBPC) autograft in 113 lymphoma patients: high tolerability with reversible cardiotoxicity
C Tarella, F Zallio, D Caracciolo, et al.
Page
of 53